Moxifloxacin-based triple therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Moxifloxacin-based triple therapy, covering 2013-02-15 to 2013-02-15. Get the full timeline:
Most recent: Clinical Trial Update: Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy [Phase 4]